Active	Status	Sponsor type	Region	Phase	Filter
2 Active 1 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
ranpirnase ophthalmic (OKG-0301) / Okogen
ACTRN12619000177156: OKG-0301 for the Treatment of Acute Adenoviral Conjunctivitis	Recruiting	2	219			Okogen Pty Ltd, Okogen Pty Ltd	Adenoviral Conjunctivitis, Infectious Conjunctivitis, Viral Conjunctivitis
RUBY, NCT03856645: OKG-0301 for the Treatment of Acute Adenoviral Conjunctivitis	Active, not recruiting	2	219	RoW	OKG-0301	Okogen	Adenoviral Conjunctivitis	06/22	06/22